Schedule 13G ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,958,912
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-15-003452
Form type
SC 13G/A
Filer
PALVELLA THERAPEUTICS, INC.
CIK
CIK 1583648
Filed
Nov 24, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub